Missed NVDA?
Don’t Miss the Next One.
Join 5,000+ investors using Ticker Nerd’s Market Radar to stay ahead of major market moves, analyst upgrades, and trending opportunities — for free.
CERT Stock Forecast 2026-2027
$9.32
Current Price
$1.52B
Market Cap
Buy 8
Hold 6
Sell 0
Wall St Analyst Ratings
Distance to CERT Price Targets
+71.7%
To High Target of $16.00
+28.8%
To Median Target of $12.00
-3.4%
To Low Target of $9.00
CERT Price Momentum
-0.1%
1 Week Change
+7.6%
1 Month Change
-20.7%
1 Year Change
+5.8%
Year-to-Date Change
-40.6%
From 52W High of $15.69
+16.1%
From 52W Low of $8.03
📊 TOP ANALYST CALLS
Did CERT Make This Month's Elite Buy List?
We don't follow just any analyst — only the top 3% with a proven track record make our cut. See if Certara is one of their latest high-conviction picks.
Latest CERT Stock Price Targets & Analyst Predictions
Based on our analysis of 17 Wall Street analysts, CERT has a bullish consensus with a median price target of $12.00 (ranging from $9.00 to $16.00). The overall analyst rating is Strong Buy (8.1/10). Currently trading at $9.32, the median forecast implies a 28.8% upside. This outlook is supported by 8 Buy, 6 Hold, and 0 Sell ratings.
The most optimistic forecast comes from Scott Schoenhaus at Keybanc, projecting a 71.7% upside. Conversely, the most conservative target is provided by Sean Dodge at BMO Capital, suggesting a 3.4% downside.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
CERT Analyst Ratings
8
Buy
6
Hold
0
Sell
CERT Price Target Range
Low
$9.00
Average
$12.00
High
$16.00
Current: $9.32
Latest CERT Stock Forecasts by Analyst
These are the latest 20 analyst ratings and price targets for CERT.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|---|---|---|---|---|
| Jan 8, 2026 | Keybanc | Scott Schoenhaus | Overweight | Maintains | $12.00 |
| Jan 6, 2026 | Leerink Partners | Michael Cherny | Outperform | Upgrade | $13.00 |
| Dec 18, 2025 | Morgan Stanley | Sean Laaman | Equal-Weight | Maintains | $12.00 |
| Dec 15, 2025 | Barclays | Luke Sergott | Overweight | Maintains | $13.00 |
| Dec 12, 2025 | Stephens & Co. | Jeff Garro | Overweight | Maintains | $12.00 |
| Nov 13, 2025 | BMO Capital | Sean Dodge | Market Perform | Initiates | $9.00 |
| Nov 7, 2025 | Barclays | Luke Sergott | Overweight | Maintains | $14.00 |
| Oct 8, 2025 | Keybanc | Scott Schoenhaus | Overweight | Maintains | $16.00 |
| Oct 2, 2025 | Barclays | Luke Sergott | Overweight | Maintains | $16.00 |
| Sep 29, 2025 | Craig-Hallum | Matthew Hewitt | Buy | Initiates | $16.00 |
| Aug 7, 2025 | UBS | Dan Leonard | Buy | Maintains | $15.00 |
| Jul 14, 2025 | Keybanc | Scott Schoenhaus | Overweight | Maintains | $15.00 |
| Jul 3, 2025 | Morgan Stanley | Sean Laaman | Equal-Weight | Assumes | $16.00 |
| May 8, 2025 | Barclays | Luke Sergott | Overweight | Upgrade | $14.00 |
| May 6, 2025 | JMP Securities | Constantine Davides | Market Perform | Reiterates | $N/A |
| Apr 16, 2025 | Keybanc | Scott Schoenhaus | Overweight | Maintains | $18.00 |
| Apr 11, 2025 | Baird | Joe Vruwink | Neutral | Maintains | $13.00 |
| Apr 10, 2025 | Barclays | Luke Sergott | Equal-Weight | Maintains | $11.00 |
| Feb 28, 2025 | Barclays | Luke Sergott | Equal-Weight | Maintains | $13.00 |
| Feb 27, 2025 | Stephens & Co. | Jeff Garro | Overweight | Reiterates | $17.00 |
Certara, Inc. (CERT) Competitors
The following stocks are similar to Certara based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
Certara, Inc. (CERT) Financial Data
Certara, Inc. has a market capitalization of $1.52B with a P/E ratio of 130.7x. The company generates $415.55M in trailing twelve-month revenue with a 2.6% profit margin.
Revenue growth is +10.3% quarter-over-quarter, while maintaining an operating margin of +6.5% and return on equity of +1.0%.
Valuation Metrics
Market Cap
$1.52B
Enterprise Value
$1.59B
P/E Ratio
130.7x
PEG Ratio
-0.7x
Price/Sales
3.5x
Growth & Margins
Revenue Growth (YoY)
+10.3%
Gross Margin
+62.0%
Operating Margin
+6.5%
Net Margin
+2.6%
EPS Growth
+10.3%
Financial Health
Cash/Price Ratio
+11.6%
Current Ratio
2.1x
Debt/Equity
29.0x
ROE
+1.0%
ROA
+1.3%
💡 SKIP THE NOISE
97% of Analyst Ratings Go Nowhere
We filter thousands of calls to find the few that actually matter. Get the top analyst buy ratings — tracked and updated every Monday and Thursday.
Certara, Inc. (CERT) Business Model
About Certara, Inc.
What They Do
Provides biosimulation and regulatory software solutions.
Business Model
Certara generates revenue by offering advanced technology and software solutions that assist pharmaceutical companies in drug discovery and development. Their products, such as Simcyp and Phoenix, are utilized for modeling and simulation, enabling clients to predict drug behavior and optimize clinical trials, thus reducing costs and time to market.
Additional Information
The company collaborates with major pharmaceutical and biotech firms worldwide, playing a crucial role in enhancing healthcare through therapeutic innovation. Certara's expertise in pharmacokinetics and pharmacodynamics positions it as a key player in the biopharmaceutical industry, making it an attractive investment opportunity.
Company Information
Sector
Healthcare
Industry
Health Information Services
Employees
1,487
CEO
Mr. Jon Resnick
Country
United States
IPO Year
2020
Website
www.certara.comCertara, Inc. (CERT) Latest News & Analysis
Latest News
Quick Summary
Kopion Asset Management acquired 327,064 shares of Certara for $3.37 million in Q4, increasing the position's value by $645,681 due to share additions and price changes.
Why It Matters
Kopion Asset Management's significant investment in Certara and the rising value of its position signal confidence in the company's growth potential, attracting attention from other investors.
Source: The Motley Fool
Market Sentiment:
Neutral
Quick Summary
Insider share ownership and corporate profitability are crucial factors for identifying stocks that may have been temporarily undervalued.
Why It Matters
Insider ownership signals confidence in a company's future, while profitability indicates stability. Both factors can identify undervalued stocks ripe for recovery.
Source: Market Watch
Market Sentiment:
Positive
Quick Summary
Resnick has extensive leadership experience in health sciences, business operations, strategy, innovation, and commercial growth.
Why It Matters
Resnick's extensive experience in health sciences and business operations suggests potential for strategic growth and innovation, which could positively impact company performance and stock value.
Source: GlobeNewsWire
Market Sentiment:
Neutral
Quick Summary
Certara, Inc. (CERT) shares are gaining momentum, supported by positive earnings estimate revisions, suggesting potential for continued growth in the near term.
Why It Matters
Rising earnings estimates for Certara, Inc. suggest potential stock price appreciation, signaling positive sentiment and growth prospects for investors.
Source: Zacks Investment Research
Market Sentiment:
Positive
Wall Street Analysts Think Certara (CERT) Could Surge 43.28%: Read This Before Placing a Bet
1 month ago
Quick Summary
Wall Street analysts project a 43.3% potential upside for Certara (CERT), supported by positive earnings estimate revisions.
Why It Matters
The 43.3% upside in price targets suggests strong potential for Certara's stock growth, while positive earnings revisions may further boost investor confidence and stock performance.
Source: Zacks Investment Research
Market Sentiment:
Positive
Quick Summary
Cerrado Gold Inc. (CERT:CA) held its Q3 2025 earnings call, discussing financial performance and operational updates. Further details can be found in the full transcript.
Why It Matters
Cerrado Gold's Q3 2025 earnings call reveals financial performance, operational insights, and future guidance, impacting stock valuation and investment decisions.
Source: Seeking Alpha
Market Sentiment:
Neutral
Frequently Asked Questions About CERT Stock
What is Certara, Inc.'s (CERT) stock forecast for 2026?
Based on our analysis of 17 Wall Street analysts, Certara, Inc. (CERT) has a median price target of $12.00. The highest price target is $16.00 and the lowest is $9.00.
Is CERT stock a good investment in 2026?
According to current analyst ratings, CERT has 8 Buy ratings, 6 Hold ratings, and 0 Sell ratings. The stock is currently trading at $9.32. Always conduct your own research and consider your investment goals before making investment decisions.
What is the long-term price prediction for CERT stock?
Wall Street analysts predict CERT stock could reach $12.00 in the next 12 months. This represents a 28.8% increase from the current price of $9.32. Please note that this is a projection by Wall Street analysts and not a guarantee.
What is Certara, Inc.'s business model?
Certara generates revenue by offering advanced technology and software solutions that assist pharmaceutical companies in drug discovery and development. Their products, such as Simcyp and Phoenix, are utilized for modeling and simulation, enabling clients to predict drug behavior and optimize clinical trials, thus reducing costs and time to market.
What is the highest forecasted price for CERT Certara, Inc.?
The highest price target for CERT is $16.00 from Scott Schoenhaus at Keybanc, which represents a 71.7% increase from the current price of $9.32.
What is the lowest forecasted price for CERT Certara, Inc.?
The lowest price target for CERT is $9.00 from Sean Dodge at BMO Capital, which represents a -3.4% decrease from the current price of $9.32.
What is the overall CERT consensus from analysts for Certara, Inc.?
The overall analyst consensus for CERT is bullish. Out of 17 Wall Street analysts, 8 rate it as Buy, 6 as Hold, and 0 as Sell, with a median price target of $12.00.
How accurate are CERT stock price projections?
Stock price projections, including those for Certara, Inc., are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
Important Disclaimer
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.
Last updated: January 15, 2026 9:59 PM UTC